The project aims to address the needs of deaf patients 22.5 individual in the eu. By performing resaerech wich will lead to high quality genetic counselling and the discovery of curative treatements. To fulfil these expectations a number of human deafness will be isolated and moleculare daignastic test associated with a detailed clinicale description of the differnt gene defect will be developed. The major challenge i.e. the development nof new therapies will be tackled direclty as well as by elucuidating the underling dfective patwaays. To achieve this conplementary approaches will be set up and mouse and zebrafisch model for human daefness will be generated witch much effort on the connexin 26 gene defect 50% of congenitale deafness .the role of daefness gene in the susceptibility to environmentale causes of hearing loss .i.e. to noise and aminoglglycosides will be also analysed. Finally the consortium will produce epidemiologicale data on hereditary daefness in the eu.
Funding SchemeCSC - Cost-sharing contracts
OX11 0RD Didcot,harwell,chilton
69978 Ramat - Aviv
M13 9PL Manchester